M6P Therapeutics’ publications are listed below:
Engineering Of GlcNAc-1-Phosphotransferase For Production Of Highly Phosphorylated Lysosomal Enzymes For Enzyme Replacement Therapy. Mol Ther Methods Clin Dev. 2017 Jun 16; 5: 59–65.
A new platform technology for next generation lysosomal enzyme replacement and potential gene therapy in the treatment of lysosomal diseases. Poster session at WORLDSymposium, February 11, 2020.